Cargando…
1573 Use of protease inhibitors is associated with higher selenium levels in treated HIV infection
Autores principales: | Kumar, Jessica, Hileman, Corrilynn, Storer, Norma J., Labbato, Danielle E., Combs, Gerald, Mccomsey, Grace A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781843/ http://dx.doi.org/10.1093/ofid/ofu052.1119 |
Ejemplares similares
-
Fatty Liver Disease in HIV: Predictors and Response to Statin Therapy
por: El Kamari, Vanessa, et al.
Publicado: (2017) -
Impact of Heroin and HIV on Gut Integrity and Immune Activation
por: Hileman, Corrilynn O., et al.
Publicado: (2022) -
1609 Plasma markers of immune activation likely reflect related but distinct processes of cellular immune activation in HIV-infected persons before and after suppression of viremia by antiretroviral therapy: ACTG 5260
por: Kelesidis, Theodoros, et al.
Publicado: (2014) -
1567 Simplification to elvitegravir/cobicistat/emtricitabine/tenofovir DF from ritonavir-boosted protease inhibitor plus emtricitabine/tenofovir DF maintains HIV suppression and improves fasting triglycerides at week 48
por: Cunningham, Douglas, et al.
Publicado: (2014) -
1000 Effect of Cytomegalovirus Infection on Breastfeeding Transmission of HIV and on the Health of Infants Born to HIV-infected Mothers
por: Chang, Tiffany, et al.
Publicado: (2014)